Arcadia Investment Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$858K Sell
3,943
-110
-3% -$24.4K 0.15% 72
2025
Q4
$926K Sell
4,053
-405
-9% -$92.3K 0.15% 72
2025
Q3
$1.03M Sell
4,458
-562
-11% -$114K 0.16% 69
2025
Q2
$932K Sell
5,020
-285
-5% -$53K 0.15% 72
2025
Q1
$1.11M Sell
5,305
-2,174
-29% -$423K 0.2% 66
2024
Q4
$1.33M Sell
7,479
-201
-3% -$37K 0.21% 65
2024
Q3
$1.52M Sell
7,680
-20
-0.3% -$3.73K 0.25% 58
2024
Q2
$1.32M Sell
7,700
-1,671
-18% -$277K 0.23% 61
2024
Q1
$1.71M Buy
9,371
+59
+0.6% +$10.2K 0.3% 56
2023
Q4
$1.44M Buy
9,312
+1,666
+22% +$243K 0.28% 57
2023
Q3
$1.14M Hold
7,646
0.24% 62
2023
Q2
$1.03M Sell
7,646
-4,612
-38% -$676K 0.21% 63
2023
Q1
$1.95M Sell
12,258
-275
-2% -$42K 0.43% 51
2022
Q4
$2.03M Buy
12,533
+3,902
+45% +$598K 0.47% 51
2022
Q3
$1.16M Sell
8,631
-290
-3% -$41.6K 0.28% 64
2022
Q2
$1.37M Buy
8,921
+213
+2% +$32.5K 0.3% 64
2022
Q1
$1.41M Buy
8,708
+413
+5% +$60K 0.27% 64
2021
Q4
$1.12M Buy
8,295
+1,055
+15% +$125K 0.19% 82
2021
Q3
$781K Sell
7,240
-250
-3% -$28.6K 0.14% 93
2021
Q2
$844K Sell
7,490
-725
-9% -$81.7K 0.16% 89
2021
Q1
$889K Sell
8,215
-300
-4% -$32.1K 0.18% 82
2020
Q4
$912K Sell
8,515
-4,675
-35% -$449K 0.19% 75
2020
Q3
$1.16M Sell
13,190
-825
-6% -$77.7K 0.25% 67
2020
Q2
$1.38M Sell
14,015
-900
-6% -$79.2K 0.34% 62
2020
Q1
$1.14M Sell
14,915
-1,575
-10% -$134K 0.34% 60
2019
Q4
$1.46M Sell
16,490
-6,820
-29% -$566K 0.37% 58
2019
Q3
$1.76M Sell
23,310
-2,684
-10% -$184K 0.48% 51
2019
Q2
$1.89M Sell
25,994
-32,639
-56% -$2.57M 0.52% 51
2019
Q1
$4.72M Sell
58,633
-5,725
-9% -$468K 1.37% 24
2018
Q4
$5.93M Sell
64,358
-5,813
-8% -$511K 1.99% 17
2018
Q3
$6.64M Sell
70,171
-13,193
-16% -$1.25M 1.75% 19
2018
Q2
$7.72M Sell
83,364
-15,557
-16% -$1.52M 2.15% 11
2018
Q1
$9.36M Sell
98,921
-2,640
-3% -$290K 2.64% 5
2017
Q4
$9.82M Buy
101,561
+3,070
+3% +$289K 2.75% 5
2017
Q3
$8.75M Buy
98,491
+4,590
+5% +$349K 2.67% 5
2017
Q2
$6.81M Sell
93,901
-545
-0.6% -$36.6K 2.16% 10
2017
Q1
$6.15M Sell
94,446
-851
-0.9% -$53.5K 1.94% 13
2016
Q4
$5.97M Buy
95,297
+7,475
+9% +$456K 1.95% 11
2016
Q3
$5.54M Sell
87,822
-3,078
-3% -$199K 1.84% 12
2016
Q2
$5.63M Buy
90,900
+22,116
+32% +$1.35M 1.83% 15
2016
Q1
$3.93M Sell
68,784
-5,171
-7% -$288K 1.29% 28
2015
Q4
$4.38M Sell
73,955
-7,127
-9% -$410K 1.34% 26
2015
Q3
$4.41M Sell
81,082
-1,092
-1% -$71.1K 1.35% 27
2015
Q2
$5.52M Buy
82,174
+478
+0.6% +$31.2K 1.44% 27
2015
Q1
$4.78M Sell
81,696
-930
-1% -$56.2K 1.34% 29
2014
Q4
$5.41M Buy
82,626
+12,095
+17% +$763K 1.53% 27
2014
Q3
$4.07M Buy
70,531
+44,590
+172% +$2.48M 1.22% 35
2014
Q2
$1.46M Sell
25,941
-1,550
-6% -$81.3K 0.43% 63
2014
Q1
$1.41M Sell
27,491
-13,411
-33% -$678K 0.41% 66
2013
Q4
$2.16M Sell
40,902
-700
-2% -$34.4K 0.51% 60
2013
Q3
$1.86M Sell
41,602
-500
-1% -$22.2K 0.49% 62
2013
Q2
$1.74M Buy
+42,102
New +$1.84M 0.49% 64

Other funds holding ABBV

Arcadia Investment Management's ABBV Position: Q1 2026 in Review

Arcadia Investment Management reduced its AbbVie (ABBV) stake by 2.7% in Q1 2026, selling an estimated $24.4K and leaving 3,943 shares worth $858K. The position accounts for 0.15% of the portfolio, ranked #72.

Arcadia Investment Management first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $9.82M in Q4 2017. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Arcadia Investment Management held 3,943 shares of AbbVie worth $858K as of Q1 2026.
  • Arcadia Investment Management sold 110 AbbVie shares in Q1 2026, an estimated $24.4K.
  • AbbVie made up 0.15% of Arcadia Investment Management's portfolio in Q1 2026, its #72 holding.
  • Arcadia Investment Management first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
  • Arcadia Investment Management's AbbVie position peaked at $9.82M in Q4 2017.
  • 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Arcadia Investment Management's 13F filing for Q1 2026, filed 22 Apr 2026.